(Q33228359)

24 July 2017

title

The palliative value of tumor necrosis factor alpha-based isolated limb perfusion in patients with metastatic sarcoma and melanoma (English)

1 reference

24 July 2017

5

Alexander M M Eggermont

1 reference

24 July 2017

Dirk J Grunhagen

1

1 reference

24 July 2017

Johannes H W de Wilt

series ordinal

2

1 reference

24 July 2017

Wilfried J Graveland

series ordinal

3

1 reference

24 July 2017

Albertus N van Geel

series ordinal

4

1 reference

24 July 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

24 July 2017

1 reference

24 July 2017

volume

106

1 reference

24 July 2017

issue

1

1 reference

24 July 2017

page(s)

156-162

1 reference

Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities

24 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

Localized Extremity Soft Tissue Sarcoma: Improved Knowledge With Unchanged Survival Over Time

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

Isolated limb perfusion with tumor necrosis factor‐α and melphalan for patients with unresectable soft tissue sarcoma of the extremities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

Rationale for using TNF alpha and chemotherapy in regional therapy of melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

Isolated limb perfusion with tumor necrosis factor and melphalan for limb salvage in 186 patients with locally advanced soft tissue extremity sarcomas. The cumulative multicenter European experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

Dosimetry in isolation perfusion of the limbs by assessment of perfused tissue volume and grading of toxic tissue reactions

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

Prognostic factors in soft tissue sarcomas: a study of 395 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

Treatment of patients with melanoma of the extremity using hyperthermic isolated limb perfusion with melphalan, tumor necrosis factor, and interferon gamma: results of a tumor necrosis factor dose-escalation study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

One hundred consecutive isolated limb perfusions with TNF-alpha and melphalan in melanoma patients with multiple in-transit metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

Systemic toxicity and cytokine/acute phase protein levels in patients after isolated limb perfusion with tumor necrosis factor-alpha complicated by high leakage

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

The treatment of distant metastases in soft tissue sarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

Hyperthermic isolated limb perfusion with tumour necrosis factor-alpha and melphalan as palliative limb-saving treatment in patients with locally advanced soft-tissue sarcomas of the extremities with regional or distant metastases. Is it worthwhile?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.21547

7 January 2021

https://api.fatcat.wiki/v0/release/ocyhwasamzcwnhzphsb6ja3h7e

Identifiers

1 reference

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_ocyhwasamzcwnhzphsb6ja3h7e

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ocyhwasamzcwnhzphsb6ja3h7e

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/ocyhwasamzcwnhzphsb6ja3h7e

1 reference

30 July 2022